Rajalakshmi Shantharam, MD
Obstetrics & Gynecology · Terre Haute, INNPI 1982786562
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 26.7% of the total. Reporting peaked in 2021 at $529 and has fallen 60.0% since, to $212 in 2025.
Across 98 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$493
- Myovant Sciences Inc.$265
- Astellas Pharma US Inc$158
- Agile Therapeutics, Inc.$135
- Biogen$130
- Exeltis, USA Inc.$81
- plus $582 from 21 others
What the payments were for
- Food & beverage$1,73694%
- Education$1076%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $493 |
| Myovant Sciences Inc. | 20 | $265 |
| Astellas Pharma US Inc | 5 | $158 |
| Agile Therapeutics, Inc. | 7 | $135 |
| Biogen | 5 | $130 |
| Exeltis, USA Inc. | 5 | $81 |
| Pfizer | 4 | $72 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Dexcom, Inc. | 2 | $45 |
| Novo Nordisk | 2 | $40 |
| Coopersurgical, Inc. | 2 | $34 |
| Amgen | 2 | $33 |
| Bayer | 2 | $33 |
| Duchesnay USA Incorporated | 2 | $29 |
| Axonics, Inc. | 1 | $24 |
| Organon | 2 | $24 |
| Solventum Corporation | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Shield Therapeutics Inc | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Vertex | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Coloplast | 1 | $13 |
How this compares
$1,843 in reported general payments places this provider in the 70th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Norethindrone | 15 | $436 |
| Clobetasol Propionate | 22 | $402 |
| Medroxyprogesterone Acetate | 13 | $296 |
| Spironolactone | 13 | $164 |
| Metformin Hcl ErMetformin Hcl | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Terre Haute
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Enrique InfanteElkhart$41K
- Paul MorrisonNewburgh$38K
- Joseph ShinnLafayette$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.